The principal goal was to evaluate the efficacy in the vaccine vs . placebo in cutting down cocaine use. Secondary goals bundled confirming vaccine immunogenicity via IgG anti-cocaine antibody concentrations and assessing the security and tolerability of vaccination through a 20 week analyze and at 24 week follow-up. Cocaine eye https://hatshepsutg429usr5.nytechwiki.com/user